Drug price reforms: the new F1-F2 bifurcation

Simple item page
dc.contributor.authorLofgren, Hansen_AU
dc.contributor.authorFaunce, Thomasen_AU
dc.date.accessioned2015-12-10T22:25:41Z
dc.date.issued2007
dc.date.updated2015-12-09T09:26:35Z
dc.identifier.issn0312-8008
dc.identifier.urihttp://hdl.handle.net/1885/53590
dc.publisherNational Prescribing Service
dc.rights© National Prescribing Service 2007. Publisher permission to archive the publisher version pdf 6/7/2016.
dc.sourceAustralian Prescriber
dc.subjectKeywords: generic drug; Australia; drug cost; drug industry; drug legislation; drug marketing; editorial; health care policy; human; pharmacy Generic drugs; Pharmaceutical Benefits Scheme; Reference pricing
dc.titleDrug price reforms: the new F1-F2 bifurcation
dc.typeJournal article
local.bibliographicCitation.issue6
local.bibliographicCitation.lastpage140
local.bibliographicCitation.startpage138
local.contributor.affiliationFaunce, Thomas, ANU College of Law, ANU
local.contributor.affiliationLofgren, Hans, Deakin University
local.contributor.authoruidFaunce, Thomas, u9705219
local.description.notesImported from ARIES
local.identifier.absfor180102 - Access to Justice
local.identifier.ariespublicationu9507981xPUB277
local.identifier.citationvolume30
local.identifier.scopusID2-s2.0-36849036730
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Faunce_Drug_price_reforms:_the_new_2007.pdf
Size:
739.28 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS